Varicella zoster virus vaccine (Walvax Biotech)

水痘减毒活疫苗（云南沃森生物）

Report date: 2026/02/10 11:19:42

Base Information

Drug NameVaricella zoster virus vaccine (Walvax Biotech)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Live attenuated vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsVaricella Zoster Virus Infection

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesWalvax Biotechnology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesWalvax Biotechnology Co Ltd

Inactive CompaniesN/A

Active IndicationsVaricella Zoster Virus Infection

Inactive IndicationsN/A

Other Information

ATC CodeN/A